Achieve Life Sciences, Inc. Total Liabilities and Equity
Achieve Life Sciences, Inc. (ACHV) had Total Liabilities and Equity of $190.44 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-11
- 2026-06-30: Liabilities and Equity $190.44M.
- 2026-03-31: Liabilities and Equity $33.10M.
- 2025-12-31: Liabilities and Equity $41.79M.
- 2025-09-30: Liabilities and Equity $52.04M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $190.44M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $33.10M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $41.79M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $52.04M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $58.94M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $27.36M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $38.63M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $47.92M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $64.79M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $70.03M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $19.37M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $24.34M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $28.91M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $20.80M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $29.97M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $23.72M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $33.98M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $40.61M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $47.52M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $37.80M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $45.56M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $33.66M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $40.30M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $27.62M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $16.46M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $16.65M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $21.08M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $11.49M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $14.76M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $14.50M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $19.08M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $17.14M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $19.22M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $8.46M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $9.89M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $13.03M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $14.88M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $17.90M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $3.81M 10-K · filed 2018-03-01 | $27.47M 10-K · filed 2017-02-23 |
| 2016-09-30 | $35.07M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $42.20M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $48.84M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $58.21M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $68.24M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $63.36M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $46.38M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $56.29M 10-K · filed 2016-03-09 | |
| 2014-09-30 | $62.65M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $49.73M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $49.82M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $55.69M 10-K · filed 2015-03-26 | |
| 2013-09-30 | $61.64M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $69.31M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $75.35M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $82.02M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $97.17M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $108.02M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $115.22M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $68.02M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $74.68M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $79.53M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $89.92M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |